Jefferies Maintains Buy on Verastem, Raises Price Target to $13
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
Jefferies analyst Faisal Khurshid maintains Verastem (NASDAQ:VSTM) with a Buy and raises the price target from $11 to $13.
Jefferies analyst Faisal Khurshid maintains Verastem (NASDAQ:VSTM) with a Buy and raises the price target from $11 to $13.